Daytrana Patch (methylphenidate transdermal system): Drug Safety Communication - Permanent Skin Color Changes

New warning added to drug label to describe risk of chemical leukoderma.

chemical leukoderma, have been associated with the use of the Daytrana patch.

Source: FDA MedWatch - June 24, 2015 Category: American Health Source Type: news